Prospective Fresenius Study Confirms T50 as Independent Predictor of Mortality for Hemodialysis Patients
Fresenius Medical Care presented its T50 study of 776 hemodialysis patients at the European Nephrology (ERA-EDTA) Congress. The study confirms T50 as an independent predictor of mortality in routine dialysis care.
